Stockscreener 앱 받기
33.34
0.54%
0.18
전일 마감가:
$33.16
열려 있는:
$32.98
하루 거래량:
1.40M
Relative Volume:
1.62
시가총액:
$2.54B
수익:
-
순이익/손실:
$-64.16M
주가수익비율:
-26.25
EPS:
-1.2702
순현금흐름:
$-69.06M
1주 성능:
+0.82%
1개월 성능:
+33.63%
6개월 성능:
+25.24%
1년 성능:
-4.28%
1일 변동 폭
$32.57
$34.46
1주일 범위
$32.08
$34.73
52주 변동 폭
$14.80
$40.47
Cg Oncology Inc Stock (CGON) Company Profile
명칭
Cg Oncology Inc
전화
(949) 419-6203
주소
400 SPECTRUM CENTER DRIVE, IRVINE
CGON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
33.34 | 2.56B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-07-10 | 재개 | Goldman | Buy |
| 2025-05-02 | 개시 | JP Morgan | Overweight |
| 2025-04-16 | 개시 | Scotiabank | Sector Perform |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-09-23 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2024-06-28 | 개시 | BofA Securities | Buy |
| 2024-02-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-20 | 개시 | Goldman | Neutral |
| 2024-02-20 | 개시 | Morgan Stanley | Overweight |
| 2024-02-14 | 개시 | H.C. Wainwright | Buy |
모두보기
Cg Oncology Inc 주식(CGON)의 최신 뉴스
CG Oncology, Inc. $CGON Shares Sold by Corebridge Financial Inc. - MarketBeat
Analysts Set CG Oncology, Inc. (NASDAQ:CGON) PT at $54.30 - MarketBeat
Analysts Offer Insights on NA Companies: Reddit Inc Class A (RDDT), Solventum Corporation (SOLV) and CG Oncology, Inc. (CGON) - The Globe and Mail
James Mulay Sells 27,015 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat
CG Oncology (CGON) Reports Promising Results In BOND-003 Trial - Yahoo Finance
Northern Trust Corp Grows Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
Jones Trading Begins Coverage on CG Oncology (NASDAQ:CGON) - MarketBeat
Cantor Fitzgerald Reiterates Overweight Rating for CG Oncology (NASDAQ:CGON) - MarketBeat
CG Oncology Highlights Drug Potential at Healthcare Conference - MSN
Can technical indicators confirm CG Oncology Inc.’s reversalMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Earnings visualization tools for CG Oncology Inc.CPI Data & Safe Capital Growth Tips - Newser
Is CG Oncology Inc. showing signs of accumulationPortfolio Value Summary & Weekly Consistent Profit Watchlists - Newser
Alliancebernstein L.P. Has $46.10 Million Position in CG Oncology, Inc. $CGON - MarketBeat
Combining price and volume data for CG Oncology Inc.2025 Market Overview & Fast Moving Stock Watchlists - Newser
What momentum shifts mean for CG Oncology Inc.Market Activity Report & Growth Oriented Trade Recommendations - Newser
Using flow based indicators on CG Oncology Inc.July 2025 Market Mood & Safe Entry Trade Reports - Newser
CG Oncology (NASDAQ:CGON) Now Covered by Jones Trading - Defense World
Should you hold or exit CG Oncology Inc. nowPrice Action & Low Drawdown Momentum Ideas - Newser
What machine learning models say about CG Oncology Inc.M&A Rumor & Real-Time Sentiment Analysis - Newser
Is CG Oncology Inc. building a consolidation baseJuly 2025 Earnings & Consistent Growth Equity Picks - Newser
Real time pattern detection on CG Oncology Inc. stockPortfolio Profit Report & Fast Gain Swing Alerts - Newser
Technical signs of recovery in CG Oncology Inc.Quarterly Portfolio Report & Daily Profit Focused Screening - Newser
CG Oncology (CGON) Is Up 23.3% After 24-Month Complete Response Data in Phase 3 Bladder Cancer Study - Yahoo Finance
CG Oncology stock holds Buy rating at H.C. Wainwright on strong cancer data - Investing.com Canada
Is CG Oncology Inc. stock ready for a breakoutGap Down & Weekly High Return Forecasts - Newser
CG Oncology initiated with a Buy at JonesResearch - TipRanks
JonesTrading Initiates CG Oncology at Buy With $50 Price Target - MarketScreener
Real time alert setup for CG Oncology Inc. performanceBond Market & Entry Point Confirmation Signals - Newser
Real time breakdown of CG Oncology Inc. stock performanceWeekly Stock Recap & Weekly Breakout Watchlists - Newser
What earnings revisions data tells us about CG Oncology Inc.Weekly Trend Report & Smart Money Movement Alerts - Newser
CG Oncology (NASDAQ:CGON) Raised to "Hold" at Zacks Research - MarketBeat
What is the dividend yield of CG Oncology Inc.Quarterly Trade Report & Daily Oversold Bounce Ideas - beatles.ru
Is CG Oncology Inc. stock reversal real or fake2025 Macro Impact & Daily Stock Momentum Reports - Newser
Understanding CG Oncology Inc.’s price movement2025 Price Momentum & Breakout Confirmation Alerts - Newser
ADAR1 Capital Management LLC Has $7.38 Million Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
is cg oncology inc. still worth holding after the dip2025 Market Trends & High Accuracy Swing Entry Alerts - Newser
Using economic indicators to assess CG Oncology Inc. potentialEarnings Overview Report & Safe Entry Momentum Stock Tips - Newser
Using R and stats models for CG Oncology Inc. forecastingTrade Ideas & Weekly High Momentum Picks - Newser
What moving averages say about CG Oncology Inc.Portfolio Profit Report & Expert Verified Movement Alerts - Newser
CG Oncology Inc. stock trend forecastMarket Risk Analysis & Accurate Entry and Exit Point Alerts - Newser
What are CG Oncology Inc.’s technical support levels2025 Short Interest & Community Verified Swing Trade Signals - خودرو بانک
Wall Street Analysts Believe CG Oncology, Inc. (CGON) Could Rally 157.91%: Here's is How to Trade - MSN
CG Oncology reports 41.8% complete response rate at 24 months for bladder cancer drug - Investing.com Canada
Will CG Oncology Inc. outperform the marketTrade Analysis Report & Consistent Profit Focused Trading Strategies - Newser
CG Oncology reports 41.8% complete response rate at 24 months for bladder cancer drug By Investing.com - Investing.com South Africa
CG Oncology stock rises on strong bladder cancer treatment durability data - Investing.com
Is CG Oncology Inc. a candidate for recovery playTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Updated BOND-003 data support durability of cretostimogene grenadenorepvec in NMIBC - Urology Times
CG Oncology stock rises on strong bladder cancer treatment durability data By Investing.com - Investing.com South Africa
Cg Oncology shares rise 5.20% premarket after announcing positive 24-month complete response rate for cretostimogene. - AInvest
CG Oncology Says Investigational Bladder Cancer Drug Shows 'Robust' Response - MarketScreener
Cg Oncology Inc (CGON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.10%
자본화:
|
볼륨(24시간):